Study of INKmune in Patients With mCRPC (CaRe Prostate)

Clinical trial NCT06056791 · COMPLETED

Trial details

NCT number: NCT06056791
Sponsor: Inmune Bio, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Metastatic Castration-resistant Prostate Cancer mCRPC

Start date: 2023-11-30
Primary completion: 2025-09-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.